IPOGrid
0002131813
IPO filing research

newcleo plc

Fabricated Plate Work (Boiler Shops) · NWCL

follow-on filed Nasdaq F-1

newcleo plc IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: F-1 on 2026-10-06. Current deal snapshot: exchange Nasdaq.

Filing Timeline

SEC EDGAR
F-1 filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
2,625,000 shares
Class A · Over-allotment 2,625,000 · Selling stockholders only · Use of proceeds Selling stockholders with no issuer proceeds · Flags units
Newcleo PLC's F-1 filing highlights a 46% revenue increase to €19.4 million for the six months ended June 30, 2026, driven by manufacturing growth and consultancy services. However, significant operating losses persist, with a €81.1 million loss in the same period. Year-over-year, 2025 revenue fell 30% to €32.8 million, attributed to internal project prioritization. Key financial shifts include rising SG&A expenses, reduced R&D costs, and a new share of loss from associates. The company faces ongoing challenges in balancing internal R&D with external revenue generation.
2026-10-06 · 0001140361-26-038802
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-09-21 · 0001354457-26-000889
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
First tracked pre-IPO filing for this issuer.
2026-09-21 · 0001140361-26-037195
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-09-10 · 0000950103-26-013784
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-09-10 · 0000950103-26-013781
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-09-04 · 0000950103-26-013626
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-08-26 · 0000950103-26-012935
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-08-11 · 0000950103-26-012138
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
First tracked pre-IPO filing for this issuer.
20,217,378 shares
Class A · Exchange NASDAQ · Ticker NHIC · 10,062,500 warrants to purchase ordinary shares · Flags cayman_holding_company, foreign_private_issuer
newcleo Ltd.'s current 424B3 filing outlines illustrative revenue streams from IP license fees, pre-COD services, post-COD services, and MOX fuel sales, all subject to significant uncertainties. The company highlights risks related to variable customer negotiations, competitive pressures, regulatory challenges, and reliance on subsidiary support and future acquisitions. Key assumptions about revenue timing and pricing remain conditional on ongoing discussions and market dynamics, with potential material impacts on financial projections.
2026-08-10 · 0001140361-26-031950
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
First tracked pre-IPO filing for this issuer.
2026-08-06 · 9999999995-26-002562
F-4/A amended
F-4/A
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-08-03 · 0001140361-26-030583
F-4/A amended
F-4/A
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
20,217,378 shares
Ordinary Shares · Exchange NASDAQ · Warrants to purchase ordinary shares · Use of proceeds Use of proceeds is for the business combination and capital restructuring · Flags cayman_holding_company, units, warrants
2026-07-27 · 0001140361-26-029640
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows F-4 in the pre-IPO sequence.
2026-07-09 · 0000950103-26-010470
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-07-09 · 0000950103-26-010469
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-07-09 · 0000950103-26-010468
F-4 filed
F-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
20,217,378 shares
Ordinary · Exchange Nasdaq · Ticker NEWCLEO · 10,062,500 Warrants to Purchase Ordinary Shares · Selling stockholders only · Use of proceeds Selling stockholders
2026-07-06 · 0001140361-26-027646
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-30 · 0000950103-26-009839
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-22 · 0000950103-26-009292
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-17 · 0000950103-26-009160
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-15 · 0000950103-26-008991
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-12 · 0000950103-26-008935
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows DRS in the pre-IPO sequence.
2026-06-10 · 0000950103-26-008791
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-03 · 0000950103-26-008380
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after 425.
The current DRS filing for newcleo plc includes illustrative revenue streams and capacity figures that are not guarantees of future performance. The company emphasizes that these estimates are based on assumptions and are subject to significant uncertainties, including customer negotiations, market conditions, regulatory changes, and technological challenges. The filing highlights the early-stage nature of the business and the risks associated with achieving projected revenues and operational milestones.
2026-06-02 · 0001140361-26-023711
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-01 · 0000950103-26-008204
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-06-01 · 0000950103-26-008203
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-29 · 0000950103-26-007983
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-29 · 0000950103-26-007981
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-27 · 0000950103-26-007826
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-27 · 0000950103-26-007821
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-27 · 0000950103-26-007817
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2026-05-27 · 0000950103-26-007812
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
First tracked pre-IPO filing for this issuer.
2026-05-27 · 0000950103-26-007808
Comparable Deals

2 comparable deals

IndustrialsLast 18 months
Only 0 strict matches; expanded to 2 using nearest neighbors.
+32.6%
Median day-1
100%
Above issue
+26.5%
Median week-1
+27.9%
Downside (p10)